Evidence map›Paper›PMID 34944096›Full record

ArticleCells2021

Potential Antagonistic Bacteria against

Xiaofeng Su, Siyuan Wu, Lu Liu, Guoqing Lu, Haiyang Liu, Xi Jin, Yi Wang, Huiming Guo, Chen Wang, Hongmei Cheng

Abstract read
In one paragraph

Article in Cells, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Heat Shock Transcription Factor GhHSFB2a Is Crucial for Cotton Resistance toInternational journal of molecular sciences · 2023
    Article
  4. Detection and quantification ofFrontiers in cellular and infection microbiology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Xiaofeng SuBiotechnology Research Institute, Chinese Academy of Agricultural Sciences, Beijing 100081, China.ORCID 0000-0003-0270-9569
Siyuan WuBiotechnology Research Institute, Chinese Academy of Agricultural Sciences, Beijing 100081, China.
Lu LiuBiotechnology Research Institute, Chinese Academy of Agricultural Sciences, Beijing 100081, China.
Guoqing LuBiotechnology Research Institute, Chinese Academy of Agricultural Sciences, Beijing 100081, China.
Haiyang LiuInstitute of Plant Protection, Xinjiang Academy of Agricultural Sciences, Urumqi 830091, China.
Xi JinHebei Technology Innovation Center for Green Management of Soil-Borne Diseases, Baoding University, Baoding 071000, China.
Yi WangQiannan Branch of Guizhou Provincial Tobacco Corporation, Qiannan 550100, China.
Huiming GuoBiotechnology Research Institute, Chinese Academy of Agricultural Sciences, Beijing 100081, China.
Chen WangBiotechnology Research Institute, Chinese Academy of Agricultural Sciences, Beijing 100081, China.
Hongmei ChengBiotechnology Research Institute, Chinese Academy of Agricultural Sciences, Beijing 100081, China.ORCID 0000-0002-6550-8732

Funding

Hebei Technology Innovation Center for Green Management of Soil-borne Diseases (Baoding University) 2021K09National Natural Science Foundation of China 31772244National Natural Science Foundation of China 32072376National Natural Science Foundation of China 32160624Project of the Innovation Team Building in Key Areas of Xinjiang Production and Construction Corps (XPCC) 2019CB008
6 · The paper itself

Abstract

As an ecofriendly biocontrol agent, antagonistic bacteria are a crucial class of highly efficient fungicides in the field against

Indexed as

AscomycotaBacteriaDisease ResistanceExtracellular SpaceGene Expression Regulation, PlantGossypiumLipopeptidesPest Control, BiologicalPhylogenyPlant DiseasesVerticilliumLipopeptidesbiocontrol fungicidescottonextracellular enzymenonribosomal peptidesresistant gene expression

Identifiers

PMID34944096
PMCPMC8699867

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.